Literature DB >> 16759708

Bioactive sphingolipids in the modulation of the inflammatory response.

Mazen El Alwani1, Bill Xingjun Wu, Lina M Obeid, Yusuf A Hannun.   

Abstract

Inflammation is viewed as a protective response against insults to the organism. It involves the recruitment of many cell types and the production of various inflammatory mediators in attempts to contain and reverse the insult. However, inflammation can lead to irreversible tissue destruction by itself and, therefore, can represent a disease state that causes significant morbidity and mortality. Understanding the molecular mechanisms controlling the inflammatory response is essential to formulate therapeutic strategies for the treatment of inflammatory conditions. In fact, substantial research has unveiled important aspects of the inflammatory machinery, both at the cellular and molecular levels. Recently, sphingolipids (SLs) have emerged as signaling molecules that regulate many cell functions, and ample evidence emphasizes their role in the regulation of inflammatory responses. Here, we review the role of bioactive SL as regulators and mediators of inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16759708     DOI: 10.1016/j.pharmthera.2006.04.004

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  56 in total

1.  Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis.

Authors:  DeAnna A Baker; Jeremy Barth; Raymond Chang; Lina M Obeid; Gary S Gilkeson
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

2.  Periodontal inflammation and alveolar bone loss induced by Aggregatibacter actinomycetemcomitans is attenuated in sphingosine kinase 1-deficient mice.

Authors:  H Yu; C Sun; K M Argraves
Journal:  J Periodontal Res       Date:  2015-04-20       Impact factor: 4.419

3.  Exogenous ceramide-1-phosphate (C1P) and phospho-ceramide analogue-1 (PCERA-1) regulate key macrophage activities via distinct receptors.

Authors:  Sebastián Katz; Orna Ernst; Dorit Avni; Muhammad Athamna; Amir Philosoph; Lide Arana; Alberto Ouro; L Alexis Hoeferlin; Michael M Meijler; Charles E Chalfant; Antonio Gómez-Muñoz; Tsaffrir Zor
Journal:  Immunol Lett       Date:  2015-12-03       Impact factor: 3.685

4.  Serum Metabonomics of Mild Acute Pancreatitis.

Authors:  Hongmin Xu; Lei Zhang; Huan Kang; Jiandong Zhang; Jie Liu; Shuye Liu
Journal:  J Clin Lab Anal       Date:  2016-05-12       Impact factor: 2.352

Review 5.  Sphingolipids in inflammation: pathological implications and potential therapeutic targets.

Authors:  Graeme F Nixon
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

Review 6.  A systems-theoretical framework for health and disease: inflammation and preconditioning from an abstract modeling point of view.

Authors:  Eberhard O Voit
Journal:  Math Biosci       Date:  2008-09-27       Impact factor: 2.144

7.  Fingolimod affects gene expression profile associated with LPS-induced memory impairment.

Authors:  Rana Omidbakhsh; Banafshe Rajabli; Sanaz Nasoohi; Behzad Khallaghi; Zahurin Mohamed; Murali Naidu; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Exp Brain Res       Date:  2014-08-07       Impact factor: 1.972

8.  Phospholipase D promotes Arcanobacterium haemolyticum adhesion via lipid raft remodeling and host cell death following bacterial invasion.

Authors:  Erynn A Lucas; Stephen J Billington; Petteri Carlson; David J McGee; B Helen Jost
Journal:  BMC Microbiol       Date:  2010-10-25       Impact factor: 3.605

9.  Migrating human neutrophils exhibit dynamic spatiotemporal variation in membrane lipid organization.

Authors:  Robert G Sitrin; Timothy M Sassanella; Jeffrey J Landers; Howard R Petty
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-20       Impact factor: 6.914

Review 10.  Thematic review series: sphingolipids. New insights into sphingolipid metabolism and function in budding yeast.

Authors:  Robert C Dickson
Journal:  J Lipid Res       Date:  2008-02-23       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.